Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05192616 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05192616 · ClinicalTrials.gov record · last posted 2025-05-16

Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease

Study acronym: iliCo
StatusActive, Not Recruiting
PhaseNot specified
Started2022-04-27
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 16, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
The objective of this prospective, multi-center, non-randomized, single-arm observational study is to evaluate the safety and the efficacy of the iCover covered stent over a 24-month follow-up period for the treatment of de novo iliac occlusive lesions, defined by a significant vessel stenosis ≥70%, in patients with symptomatic arteriopathy of the lower limbs (Rutherford class 2 to 5).

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2022-01-13. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-05-14
Status change Not Yet Recruiting→Active, Not Recruitingv1
Trial Details
NCT Number NCT05192616
Lead Sponsor iVascular S.L.U.
Conditions Angioplasty, Peripheral Arterial Disease, Iliac Artery Disease, Covered Stent, Aorto-Iliac Atherosclerosis
Enrollment 241 participants
Start Date 2022-04-27
Primary Completion 2025-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-05-16